Abstract

Hydrogen gas exists in the atmosphere and was previously considered an inert gas. It has been reported to have protective effects on tissue ischemia-reperfusion (IR) injuries in animal models. The protective mechanism of hydrogen molecules is based on selectively reducing highly strong oxidants in cells, thereby reducing inflammation and decreasing the contents of MDA, FOXO3a, and other pathways that result in flap necrosis. Previous studies were conducted with postconditioning with hydrogen. In this article, we want to investigate whether inhalation of hydrogen has a preventive effect on IR injury. Forty-five adult male Sprague Dawley rats (body weight 220-250 g) were randomly divided into three groups: (1) Sham operation group (SH), (2) Ischemia-reperfusion injury group (IR), and (3) Ischemia-reperfusion injury with preconditioning hydrogen group (PRH). IR injury was induced by clamping the right superficial epigastric artery for 3h. Before undergoing 3h of IR management, the PRH group was treated with hydrogen inhalation for 1 h. On the third postoperative day, survival area and blood perfusion of the flap were assessed using laser Doppler flowmetry. RIP1 and RIP3 were examined by immunological detection and western blot analysis. Both the IR and PRH groups had less skin flap survival area and less blood perfusion than the sham group (P<0.05). RIP1 and RIP3 were highly expressed in the IR and PRH groups when compared with those in the SH group (P<0.05). There were no significant differences in flap survival rate (32.34±2.19% and 33.09±1.64%), average blood perfusion (41.66±3.53pu, 48.57±2.83pu), and expression of RIP1 and RIP3 (0.5167±0.1409 and 0.4693±0.1454) between the IR and PRH groups. Preconditioning with one-time inhaled hydrogen does not attenuate skin flap IR injuries in rat models.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.